Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

Role of artificial intelligence in the care of patients with nonsmall cell lung cancer INTRODUCTIONLung cancer remains the most frequently diagnosed cancer and a leading cause of cancer‐related mortality worldwide. Due to late presentation of clinical symptoms and limited screening programmes, as many as 57% of patients diagnosed with lung cancer present with metastasis. Histologically, approximately 85% of all new lung cancer cases are classified as nonsmall cell lung cancers (NSCLC), 10% are small cell lung cancer (SCLC) and 5% account for other variants.Most NSCLC can be grouped into 3 main categories: Squamous Cell Carcinoma, Adenocarcinoma and Large Cell Carcinoma histo‐subtypes. Besides histological, clinical and demographic information, a wide range of data ranging from genomics, proteomics, immunohistochemistry and imaging must be integrated by physicians when developing personalized treatment plans for patients which can be challenging and lead to unfavourable outcomes. Furthermore, there are a number of factors that limit timely access to these tests, including high cost and late availability in the patient care continuum.This has led to an interest in developing computational approaches such as machine learning (ML), a subfield of artificial intelligence (AI), to improve medical management by providing insights that improve patient outcomes and workflow throughout a patient's journey. ML is the analysis and interpretation of data by machine algorithms http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Clinical Investigation Wiley

Role of artificial intelligence in the care of patients with nonsmall cell lung cancer

Loading next page...
 
/lp/wiley/role-of-artificial-intelligence-in-the-care-of-patients-with-nonsmall-zfSfLo5iOZ
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
ISSN
0014-2972
eISSN
1365-2362
D.O.I.
10.1111/eci.12901
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONLung cancer remains the most frequently diagnosed cancer and a leading cause of cancer‐related mortality worldwide. Due to late presentation of clinical symptoms and limited screening programmes, as many as 57% of patients diagnosed with lung cancer present with metastasis. Histologically, approximately 85% of all new lung cancer cases are classified as nonsmall cell lung cancers (NSCLC), 10% are small cell lung cancer (SCLC) and 5% account for other variants.Most NSCLC can be grouped into 3 main categories: Squamous Cell Carcinoma, Adenocarcinoma and Large Cell Carcinoma histo‐subtypes. Besides histological, clinical and demographic information, a wide range of data ranging from genomics, proteomics, immunohistochemistry and imaging must be integrated by physicians when developing personalized treatment plans for patients which can be challenging and lead to unfavourable outcomes. Furthermore, there are a number of factors that limit timely access to these tests, including high cost and late availability in the patient care continuum.This has led to an interest in developing computational approaches such as machine learning (ML), a subfield of artificial intelligence (AI), to improve medical management by providing insights that improve patient outcomes and workflow throughout a patient's journey. ML is the analysis and interpretation of data by machine algorithms

Journal

European Journal of Clinical InvestigationWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off